---
title: "JIUDIAN PHARMACEUTICAL: PDX-04 has been approved to conduct clinical trials for pain relief in acute gout attacks"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/241817384.md"
description: "JIUDIAN PHARMACEUTICAL recently received approval from the National Medical Products Administration to conduct clinical trials for PDX-04 for the treatment of acute gout attacks. There are currently no clinical trials or market records for this drug domestically or internationally"
datetime: "2025-05-26T09:06:06.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/241817384.md)
  - [en](https://longbridge.com/en/news/241817384.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/241817384.md)
---

# JIUDIAN PHARMACEUTICAL: PDX-04 has been approved to conduct clinical trials for pain relief in acute gout attacks

According to the Zhitong Finance APP, JIUDIAN PHARMACEUTICAL (300705.SZ) announced that it recently received the "Drug Clinical Trial Approval Notice" issued by the National Medical Products Administration. After completing the relevant preparatory work, it will carry out clinical trial research involving the drug: "PDX-04". PDX-04 is a drug used for the treatment of acute gout attacks. Currently, there are no products in this category undergoing clinical trials domestically or internationally, and there are no approved products or related sales data

### Related Stocks

- [300705.CN](https://longbridge.com/en/quote/300705.CN.md)

## Related News & Research

- [TSRL Receives Second-Year NIH Notice of Award to Advance Microneedle Patch for Overactive Bladder Therapy](https://longbridge.com/en/news/294829522.md)
- [The Precision Peptide Company Targets Launch of the Peptide Pen, Expanding Its U.S.-Made Product Platform | PNGAF Stock News](https://longbridge.com/en/news/294825312.md)
- [16:48 ETPACSUN BRINGS RECORD STORE STYLE TO OUTSIDE LANDS WITH NEW LIMITED-EDITION COLLECTION](https://longbridge.com/en/news/294554428.md)
- [Kyoto iCAP fund makes USD 600,000 follow-on investment in Kanjin Therapeutics](https://longbridge.com/en/news/294435586.md)
- [Final trade: TGT, XLE, KWEB, BMY](https://longbridge.com/en/news/294423055.md)